Temozolomide

NDC 65162-806 · Amneal Pharmaceuticals LLC

Generic nameTemozolomide

Dosage formCAPSULE

RouteORAL

Active ingredient(s)TEMOZOLOMIDE

Strength250 mg/1

Pharmacologic classAlkylating Activity [MoA], Alkylating Drug [EPC]

Marketing categoryANDA

Packages

65162-806-51 — 1 BOTTLE in 1 CARTON (65162-806-51) / 5 CAPSULE in 1 BOTTLE

J8700 — Temozolomide, oral, 5 mg Medicare Part B payment limit (ASP + 6%): $0.42

FDA lists these products with the same active ingredient.

47335-891 — Temozolomide, 47335-892 — Temozolomide, 47335-893 — Temozolomide, 47335-929 — Temozolomide, 47335-930 — Temozolomide, 65162-801 — Temozolomide, 65162-802 — Temozolomide, 65162-803 — Temozolomide, 65162-804 — Temozolomide, 65162-805 — Temozolomide, 67877-537 — Temozolomide, 67877-538 — Temozolomide, 67877-539 — Temozolomide, 67877-540 — Temozolomide, 67877-541 — Temozolomide, 67877-542 — Temozolomide, 70301-2005 — TEMOZOLOMIDE, 70301-2007 — TEMOZOLOMIDE, 70301-2009 — TEMOZOLOMIDE, 70301-2011 — TEMOZOLOMIDE, +50 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.